Biologics and Cancer Risk in RA: A Treatment Guide
11:48 EDT 27 Jul 2012 | Medscape
Dr. Jon Kay explores the relationship between anti-TNF therapy in patients with rheumatoid arthritis and the risk for malignancy. Medscape Rheumatology
Original Article: Biologics and Cancer Risk in RA: A Treatment Guide
More From BioPortfolio on "Biologics and Cancer Risk in RA: A Treatment Guide"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
